Showing results (11-20 of 44) with videos related to
Sort By:
Pageof 5
Pharmacotherapy|May 24, 2014
Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactamLindsey D Burgess, Richard H DrewPharmacy Practice|October 9, 2019
Impact of select risk factors on treatment outcome in adults with candidemiaBrandon Hill, Richard H Drew, Dustin WilsonInfection and Drug Resistance|June 23, 2011
Potential role of tigecycline in the treatment of community-acquired bacterial pneumoniaMary L Townsend, Melanie W Pound, Richard H DrewExpert Review of Anti-Infective Therapy|August 9, 2011
Ceftaroline fosamil for treatment of community-acquired pneumonia: findings from FOCUS 1 and 2 and potential role in therapyV Paul DiMondi, Richard H Drew, Luke F ChenExpert Opinion on Emerging Drugs|April 26, 2006
Emerging echinocandins for treatment of invasive fungal infectionsMichelle S Turner, Richard H Drew, John R PerfectClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2005
Is it time to abandon the use of amphotericin B bladder irrigation?Richard H Drew, Rebekah R Arthur, John R PerfectMycopathologia|March 25, 2009
Antifungal therapy for invasive fungal diseases in allogeneic stem cell transplant recipients: an updateDustin T Wilson, Richard H Drew, John R PerfectCurrent Opinion in Infectious Diseases|April 20, 2002
Recent advances in the epidemiology, prevention, diagnosis, and treatment of fungal pneumoniaMelanie W Pound, Richard H Drew, John R PerfectTherapeutics and Clinical Risk Management|June 3, 2008
Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infectionsMary L Townsend, Melanie W Pound, Richard H DrewThe Journal of Antimicrobial Chemotherapy|March 26, 2010
Echinocandin pharmacodynamics: review and clinical implicationsMelanie W Pound, Mary L Townsend, Richard H DrewPageof 5